Current position:Home >Product >
1,3-Benzenedicarboxamide, 2,4,6-tribromo-N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-
1,3-Benzenedicarboxamide, 2,4,6-tribromo-N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-(403695-63-6)
- Name: 1,3-Benzenedicarboxamide, 2,4,6-tribromo-N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-
- Synonyms:
- Molecular Formula:C16H20Br3N3O8
- Molecular Weight:
- CAS Registry Number:403695-63-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 403695-00-1/2-Propen-1-ol, 3-(9H-xanthen-9-yl)-, (2Z)-
- 403695-01-2/2-Buten-1-ol, 4-(9H-xanthen-9-yl)-, (2Z)-
- 403695-02-3/Acetic acid, diazo-, (2Z)-3-(9H-xanthen-9-yl)-2-propenyl ester
- 403695-03-4/Acetic acid, diazo-, (2Z)-4-(9H-xanthen-9-yl)-2-butenyl ester
- 403695-04-5/3-Oxabicyclo[3.1.0]hexan-2-one, 6-(9H-xanthen-9-yl)-, (1R,5S,6R)-rel-
- 403695-05-6/3-Oxabicyclo[3.1.0]hexan-2-one, 6-(9H-xanthen-9-ylmethyl)-, (1R,5S,6R)-rel-
- 403695-07-8/Morpholine, 4-[[(1R,2S,3R)-2-(hydroxymethyl)-3-(9H-xanthen-9-ylmethyl)cyclopropyl] carbonyl]-, rel-
- 403695-09-0/Morpholine, 4-[[(1R,2R,3S)-2-(hydroxymethyl)-3-(9H-xanthen-9-ylmethyl)cyclopropyl] carbonyl]-, rel-
- 403695-10-3/Morpholine, 4-[[(1R,2R,3S)-2-formyl-3-(9H-xanthen-9-yl)cyclopropyl]carbonyl]-, rel-
- 403695-11-4/Morpholine, 4-[[(1R,2R,3S)-2-formyl-3-(9H-xanthen-9-ylmethyl)cyclopropyl]carbonyl] -, rel-
- 403695-14-7/Morpholine, 4-[[(1S,2S,3R)-2-[(S)-cyano[[(1R)-2-hydroxy-1-phenylethyl]amino]methyl ]-3-(9H-xanthen-9-yl)cyclopropyl]carbonyl]-
- 403695-15-8/Morpholine, 4-[[(1S,2S,3R)-2-[(S)-cyano[[(1R)-2-hydroxy-1-phenylethyl]amino]methyl ]-3-(9H-xanthen-9-ylmethyl)cyclopropyl]carbonyl]-
- 403695-50-1/1H-Inden-1-one, 6-chloro-2,3-dihydro-2-(phenylmethylene)-, (2E)-
- 403695-51-2/1H-Inden-1-one, 2,3-dihydro-2-(3-pyridinylmethylene)-, (2E)-
- 403695-54-5/Ethanaminium, N-ethyl-N,N-dimethyl-, sulfate (1:1)
- 403695-59-0/Benzoic acid, 2,4,6-tribromo-3,5-bis[(hydroxyacetyl)amino]-
- 403695-60-3/Benzoic acid, 2,4,6-tribromo-3,5-bis[(methoxyacetyl)amino]-
- 403695-61-4/Benzoic acid, 2,4,6-tribromo-3,5-bis[[(bromomethyl)sulfonyl]amino]-
- 403695-62-5/1,3-Benzenedicarboxamide, 2,4,6-tribromo-N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]- N-methyl-
- 403695-63-6/1,3-Benzenedicarboxamide, 2,4,6-tribromo-N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]-
- 403695-68-1/1,3-Benzenedicarboxamide, 2,4,6-tribromo-5-[[(bromomethyl)sulfonyl]amino]-N,N'-bis(2,3-dihydroxy propyl)-N-methyl-
- 403695-71-6/1,3-Benzenedicarboxamide, 2,4,6-tribromo-5-[(hydroxyacetyl)amino]-N,N,N',N'-tetrakis(2-hydroxyeth yl)-
- 403695-73-8/1,3-Benzenedicarboxamide, 2,4,6-tribromo-N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)amino]- N,N'-dimethyl-
- 403695-74-9/1,3-Benzenedicarboxamide, 2,4,6-tribromo-N,N'-bis(2,3-dihydroxypropyl)-5-[(methoxyacetyl)amino]- N,N'-dimethyl-
- 403695-76-1/1,3-Benzenedicarboxamide, 5-[acetyl(2-hydroxyethyl)amino]-2,4,6-tribromo-N-[2-hydroxy-1-(hydroxy methyl)ethyl]-
- 403695-78-3/1,3-Benzenedicarboxamide, 5,5'-[oxybis[(1-oxo-2,1-ethanediyl)imino]]bis[2,4,6-tribromo-N,N'-bis(2, 3-dihydroxypropyl)-N-methyl-
- 403695-79-4/1,3-Benzenedicarboxamide, 5,5'-[(1,3-dioxo-1,3-propanediyl)diimino]bis[2,4,6-tribromo-N,N'-bis(2,3 -dihydroxypropyl)-N-methyl-
- 403695-80-7/1,3-Benzenedicarboxamide, 5,5'-[(1,3-dioxo-1,3-propanediyl)bis(methylimino)]bis[2,4,6-tribromo-N, N'-bis(2,3-dihydroxypropyl)-N-methyl-
- 403695-83-0/1,3-Benzenedicarboxamide, 5,5'-[(1,3-dioxo-1,3-propanediyl)bis[(2,3-dihydroxypropyl)imino]]bis[2,4, 6-tribromo-N-(2,3-dihydroxypropyl)-
- 403695-84-1/1,3-Benzenedicarboxamide, 5,5'-[(1,3-dioxo-1,3-propanediyl)bis(methylimino)]bis[2,4,6-tribromo-N, N'-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-